Glaukos has secured European Union Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other micro-invasive glaucoma surgery (MIGS) technologies, including the iStent ...
Glaukos has created a direct organization and initiated the commercial launch of the iStent inject Trabecular Micro-Bypass Stent in Canada. Here are five highlights: 1. The iStent inject system is ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results